While IL-22 expression is increased over the course of influenza infection in mice, the amounts of IL-22BP concurrently decrease, augmenting cytokine activity in the resolution phase of infection (Ivanov et al., 2013; Abood et al., 2019; Hebert et al., 2020). The gene discussed is IL22RA2; the disease is influenza.